HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Ward Selected Research

Biomarkers (Surrogate Marker)

5/2012Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial.
2/2011Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma.
12/2010Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours.
2/2010Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer.
5/2008Optimisation of circulating biomarkers of cell death for routine clinical use.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Ward Research Topics

Disease

7Neoplasms (Cancer)
05/2012 - 01/2001
2Necrosis
05/2012 - 02/2010
1Ketosis
01/2019
1Astrocytoma (Pilocytic Astrocytoma)
01/2019
1Glioma (Gliomas)
01/2019
1Stroke (Strokes)
02/2015
1Vitamin D Deficiency
07/2014
1Rickets (Rachitis)
07/2014
1Osteogenesis Imperfecta (Lobstein Disease)
07/2014
1Delayed Emergence from Anesthesia
03/2012
1Adenoid Cystic Carcinoma (Cylindroma)
10/2011
1Pathologic Constriction (Stenosis)
08/2011
1Chronic Limb-Threatening Ischemia
08/2011
1Sepsis (Septicemia)
02/2011
1Lymphoma (Lymphomas)
02/2011
1Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2011
1Pancreatic Neoplasms (Pancreatic Cancer)
02/2010
1Ewing Sarcoma (Sarcoma, Ewing)
07/2009
1Neuroblastoma
07/2009
1Osteosarcoma (Osteogenic Sarcoma)
07/2009
1Infertility (Sterility)
09/2001
1Ovarian Neoplasms (Ovarian Cancer)
12/2000
1Ovarian Epithelial Carcinoma
12/2000
1Infections
05/2000
1Echovirus Infections
05/2000
1Rhabdomyosarcoma
05/2000
1Picornaviridae Infections
04/2000

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
05/2012 - 05/2008
4Keratin-18 (Keratin 18)IBA
05/2012 - 05/2008
3DNA (Deoxyribonucleic Acid)IBA
02/2011 - 01/2004
2Pharmaceutical PreparationsIBA
05/2012 - 07/2009
2CaspasesIBA
02/2010 - 05/2008
2EnzymesIBA
02/2010 - 05/2008
2Proteins (Proteins, Gene)FDA Link
12/2000 - 05/2000
1Radiation-Sensitizing AgentsIBA
01/2019
13-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA
01/2019
1MagnesiumIBA
07/2014
1CopperIBA
07/2014
1TubulinIBA
05/2012
1AntigensIBA
05/2012
1Oxi 4503IBA
05/2012
1Mivacurium (Mivacron)FDA Link
03/2012
1Cisplatin (Platino)FDA LinkGeneric
10/2011
1Imatinib Mesylate (Gleevec)FDA Link
10/2011
1flt3 ligand protein (flt3 ligand)IBA
02/2011
1ParaffinIBA
12/2010
1Formaldehyde (Formol)FDA Link
12/2010
1Cell-Free Nucleic AcidsIBA
12/2010
1Becaplermin (PDGF-BB)FDA Link
05/2010
1Recombinant ProteinsIBA
05/2010
1ImmunosorbentsIBA
05/2008
1Testosterone (Sustanon)FDA Link
09/2001
1QuinonesIBA
09/2001
1Hormones (Hormone)IBA
01/2001
1Virus ReceptorsIBA
05/2000
1Complement System Proteins (Complement)IBA
05/2000
1AntibodiesIBA
05/2000
1CD55 Antigens (Decay Accelerating Factor)IBA
05/2000
1RNA (Ribonucleic Acid)IBA
04/2000

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2019 - 02/2011
1High-Protein Low-Carbohydrate Diet (Atkins Diet)
01/2019
1Brain-Computer Interfaces
02/2015
1Neurological Rehabilitation
02/2015
1Limb Salvage
08/2011
1Drug-Eluting Stents
08/2011
1Stents
08/2011
1Therapeutics
12/2010